ribociclib
novartis
['breast', 'ribociclib']
a study involving dr. dennis slamon from found when #ribociclib is added to hormone therapy, there is a significant invasive disease-free survival benefit in patients with early hr positive/her2 negative #breastcancer. read more: #medtwitter 
Leading provider of women’s health education for healthcare professionals, featuring medical news, free CME, live broadcasts, & more.